🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are just so thrilled to launch our new center website! Check out all the cool stuff we're doing in CV genetics at the Stanford Center for Inherited Cardiovascular Disease (#SCICD): med.stanford.edu/familyheart.ht…

Is there a significant difference between a 68 yr old 🫀 txp candidate and a 70 yr old? Our analysis of the SRTR registry in JHLT shows you can still have excellent outcomes in your 7th decade. Maybe it’s time to say “Okay Boomer” kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

#ESCCongress Exciting results from VAD WEAN Cardiac Recovery International Registry (>750 pts, >50 sites): a) multi-year durability of cardiac recovery equivalent to post-Transplant survival b) similarly favorable results for all HF etiologies. Wilfried Mullens Harriette Van Spall, MD MPH 🇨🇦

🔥 fresh SoA review 🔥 JACC Journals To supplement discussion of #MRA European Society of Cardiology News European Society of Cardiology We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.

Very proud of our PhD student David Ferreira who presented this important study at European Society of Cardiology Congress 2024 with simultaneous publication in EHJ Editor-in-Chief HNE Health Heart Foundation CSANZ Uni Newcastle Research Hunter Medical Research Institute (HMRI)

HCM is the most common genetic heart disease, with non-obstructive HCM lacking evidence-based treatments. IMPROVE-HCM study assesses the safety and efficacy of ninerafaxstat, a novel cardiac mitotrope. Read more! (link.springer.com/article/10.100…) Daniela Tomasoni #HREV

Thank you for inviting me! Wonderful to hear about all of your impressive work and the incredible growth of the BU MD/PhD Program program

Excited to share our latest paper: "Towards the Democratization of Subspecialty Medical Expertise." Rare heart disease illustrates a common challenge in healthcare: the scarcity of subspecialist expertise. 📜Paper: arxiv.org/abs/2410.03741 💥Podcast: drive.google.com/file/d/1a6_4Yc…

Thrilled to welcome the next batch of HF leaders to Stanford Heart Failure, Cardiac Transplant and MCS for training! Congrats 🎉🍾🎊 Alex Sandhu Joyce Njoroge, MD Aly Elezaby, MD PhD Stanford Medicine

It's well known that regular exercise is good for your health, but a new scientific consortium is revealing fresh insights into just how profound the benefits are for the human body. euan ashley, chair of Standford's Department of Medicine, is helping lead this study into how

Proud of our Stanford Heart Failure, Cardiac Transplant and MCS Stanford Cardiothoracic Surgery team and all the patients, caregivers, and donor families who entrust us with the precious gift of transplant

Is 70 the age that we should be using for a cutoff of #HeartTransplantation? These results show excellent survival outcomes from the SRTR registry in our oldest recipients in the U.S. Erik Henricksen 🔗: jhltonline.org/article/S1053-…

HFpEF remains a major challenge in CVD, marked by diastolic dysfunction & limited therapies. SERCA2a, key to Ca2+ regulation, may play a role in its pathophysiology. This SoTA #HREV (link.springer.com/article/10.100…) explores mechanisms, trials, & potential links with SGLT2i/GLP-1 drugs.

🚨 Special Issue Alert on HFpEF! 🚨 HFpEF/AF: Two common, intertwined CV conditions—particularly in older adults. Shared risk factors, complex interplay, & diagnostic challenges. Unraveling their relationship is key for therapy. #HREV 🫀✨ (link.springer.com/article/10.100…) Mark Kittipibul MD

Happy ❤️Month! Join me and Aly Elezaby, MD PhD at the Stanford Medicine My Heart Counts 5K, kids fun run and cycling event to support families with 🫀disease! Myheartcountsrun.org youtube.com/watch?v=WVRbqX…

Join us for some running/walking/cycling on April 27th!

Trying to break the mold of traditional HF fellowship with tailored tracks rather than one size fits all‼️First step is with 2⃣ amazing Stanford University programs: genetics & HF/transplant. Reach out if interested. Kiran Khush Sunny Varshney, MD Victoria Parikh, MD euan ashley Stanford Heart Failure, Cardiac Transplant and MCS The ISHLT HFSA

We're proud to announce that #StanDOM's Karim Sallam has been named the 2025 recipient of the Alwin C. Rambar – James B.D. Mark Award for Excellence in Patient Care. His compassion, dedication & teamwork define excellence at Stanford Medicine. Congratulations, Karim!

ECMO is increasingly used a bridge to transplant. In this study of the UNOS database, use of #ECMO as a bridge to multiorgan #transplant was associated with increased 30 day mortality and decreased long-term survival Elbert Heng, MD John W. MacArthur @StanfordCTSurg 🔗: